Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
3
×
fda
3
×
life sciences
national
3
×
national blog main
national top stories
new york blog main
abbvie
allergan
amgen
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
europe blog main
indiana blog main
indiana top stories
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akouos
alder biopharmaceuticals
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
What
medicines
3
×
class
fda
migraine
new
nod
acquisitions
adults
allergan
amgen
announced
approval
approved
bio
candidates
ceo
collabs
covid
daniel
deal
developed
drug
gets
gilead
gilead’s
head
help
introduce
ipo
monday
month
o’day
pain
pill
plans
preventive
roundup
sciences
starts
transformative
Language
unset
Current search:
fda
×
biotech
×
national
×
medicines
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines